EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective PAC1 Receptor Antagonist, PA-810-04 Attenuates Oxaliplatin-Induced Hyperexcitability and Coordinated Firing in Cultured Dorsal Root Ganglion Neurons

Taiyo Arima, Kazuhiro Takahama, Kimitaka Suetsugu iD, Yukiko Kobae, Haruki Iwai iD, Ichiro Takasaki iD, Takashi Kurihara iD, Hideyuki Terazono iD

International Journal of Molecular Sciences · 28.10.2026 · 27 (21) · 9665

DOI: 10.3390/ijms27219665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.10.2026. Verfasst von Taiyo Arima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima…. Hauptthemen laut MEDLINE: Ganglia, Spinal, Oxaliplatin, Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I, Neurons. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxaliplatin-induced peripheral neuropathy (OIPN) is a major dose-limiting adverse effect of chemotherapy, and dorsal root ganglion (DRG) neurons are its principal targets. Although pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1 receptor signaling has been implicated in neuropathic pain, its contribution to the oxaliplatin-induced hyperexcitability of primary sensory neurons remains unknown. We used a dual-axis multi-electrode array (MEA) platform quantifying the total spike count (TSC) and synchronous spike ratio (SSR), indices of overall activity and coordinated firing. Short-term oxaliplatin exposure produced concentration-dependent increases in TSC and SSR in cultured DRG neurons, which were significantly attenuated by the selective PAC1 receptor antagonist, PA-810-04. Similarly, conditioned medium from oxaliplatin-treated satellite glial cell (SGC)-enriched cultures increased TSC and SSR in naïve DRG neurons, and these effects were suppressed by PA-810-04. Exogenous PACAP alone increased TSC concentration-dependently, with only a modest effect on SSR, as a positive control. These findings identify a PA-810-04-sensitive component of early oxaliplatin-induced hyperexcitability in primary sensory neurons, while the proposed neuron–glia mechanism remains hypothetical. They also provide a quantitative in vitro approach for investigating neuron–glia interactions in early OIPN and evaluating PAC1-targeted candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ganglia, SpinalOxaliplatinReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type INeuronsAction PotentialsAnimalsRatsCells, CulturedMaleRats, Sprague-DawleyPituitary Adenylate Cyclase-Activating Polypeptide

Stichwörter der Autor:innen

PAC1 receptorPACAPdorsal root ganglionmultielectrode arrayoxaliplatin-induced peripheral neuropathysatellite glial cell

Substanzen

OxaliplatinReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IPituitary Adenylate Cyclase-Activating Polypeptide

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
  • Department of Pharmacy, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
  • Department of Oral Anatomy and Cell Biology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
  • Laboratory of Pharmacology, Graduate School of Pharma-Medical Sciences, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan.
  • Department of Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.

ORCID-Profile: Kimitaka Suetsugu, Haruki Iwai, Ichiro Takasaki, Takashi Kurihara, Hideyuki Terazono

Zitieren

APA

Arima, T., Takahama, K., Suetsugu, K., Kobae, Y., Iwai, H., Takasaki, I., Kurihara, T., & Terazono, H. (2026). Selective PAC1 Receptor Antagonist, PA-810-04 Attenuates Oxaliplatin-Induced Hyperexcitability and Coordinated Firing in Cultured Dorsal Root Ganglion Neurons. International Journal of Molecular Sciences, 27(21), 9665. https://doi.org/10.3390/ijms27219665

Vancouver

Arima T, Takahama K, Suetsugu K, Kobae Y, Iwai H, Takasaki I, et al. Selective PAC1 Receptor Antagonist, PA-810-04 Attenuates Oxaliplatin-Induced Hyperexcitability and Coordinated Firing in Cultured Dorsal Root Ganglion Neurons. International Journal of Molecular Sciences. 2026;27(21):9665. doi:10.3390/ijms27219665

BibTeX
@article{Arima2026,
  author = {Arima, Taiyo and Takahama, Kazuhiro and Suetsugu, Kimitaka and Kobae, Yukiko and Iwai, Haruki and Takasaki, Ichiro and Kurihara, Takashi and Terazono, Hideyuki},
  title = {Selective PAC1 Receptor Antagonist, PA-810-04 Attenuates Oxaliplatin-Induced Hyperexcitability and Coordinated Firing in Cultured Dorsal Root Ganglion Neurons},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9665},
  doi = {10.3390/ijms27219665}
}
Kostenlos starten →